Monte Rosa Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2022 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Monte Rosa Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2022 to Q2 2024.
  • Monte Rosa Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 586 %, a 50% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 586 -586 -50% Jun 30, 2024
Q1 2024 638 -704 -52.5% Mar 31, 2024
Q4 2023 798 -795 -49.9% Dec 31, 2023
Q3 2023 1.03K -886 -46.2% Sep 30, 2023
Q2 2023 1.17K -1.19K -50.3% Jun 30, 2023
Q1 2023 1.34K -1.31K -49.5% Mar 31, 2023
Q4 2022 1.59K Dec 31, 2022
Q3 2022 1.92K Sep 30, 2022
Q2 2022 2.36K Jun 30, 2022
Q1 2022 2.65K Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.